Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised ...

At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad. The SERD spectacle, the VERIFY study, and the dream of a better multi-cancer liquid biopsy test.

At ASCO Day 1, Summit Therapeutics crashes the party again, Pfizer's drug demonstrates "unprecedented" survival rate, and more. Skip to Main Content Manage alerts for this article ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

By attending ASCO, he said marketers can interface with key stakeholders, understand their perspectives and craft communications strategies accordingly. As it relates to the growing influence of ...

Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago. At-home intervention has potential to enhance cancer care delivery, outcomes. Source: Nipp RD, et al. Abstract 11003.

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

The panel discussion at the "Breathtaking Moments" event during ASCO weekend. (Johnson & Johnson) Swarner led a discussion with lung cancer survivor Maggie McCloskey, patient advocate and podcast ...

This recommendation is unchanged from the 2017 ASCO Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer 3 and the 2021 joint Ontario Health (OH; Cancer Care Ontario)-ASCO Management ...

An ASCO provisional clinical opinion offers timely clinical direction to ASCO's membership following publication or presentation of potentially practice-changing data from major studies. This ...

"ASCO is alarmed about significant proposed funding cuts to the NIH and NCI," Hudis said in the statement. "America became the global leader in medical research and innovation through deliberate ...